Not applicableNot Yet RecruitingNCT07673211
What this trial is testing
Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer
Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer
Zhejiang Cancer Hospital 60